Latest News, Stories and Reports
News
Heart Failure Treatment from Berlin Cures Shows Promise in Phase I Study.
News
BC 007 was successfully used for the treatment of a Long Covid Patient.
News
Functional autoantibodies against G protein-coupled receptors in patients with persistent Long-COVID-19 symptoms.
News
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007.
News
The DNA-Based Drug BC 007 neutralizes agonistically acting autoantibodies directed against G protein-coupled receptors.
News
Berlin Cures’ Steering Committee is Assembled to Facilitate the Design and Implementation of Phase II Study of BC 007.
News
Characterization of Aptamer BC 007 Substance and Product Using Circular Dichroism and Nuclear Magnetic Resonance Spectroscopy.
News
Berlin Cures Announces Formation of Scientific Advisory Board.
Media Coverage